Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of eletriptan 40 mg tablets in healthy Thai volunteers under fasting conditions
TCTR20220119005Phase 1Not yet recruiting
- Sponsor
- Pharmacy Service Center
- Start
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of eletriptan (2 arms), sponsored by Pharmacy Service Center. Primary endpoints: Maximum observed plasma concentration (Cmax) of eletriptan, Area under the plasma concentration-time curve from time 0 to last quantifiable concentration (AUC0-tlast) of eletriptan and 1 more. Planned start Mar 2022; status: not yet recruiting.
02
Drugs
eletriptan
Beyond the preview
Go deeper on TCTR20220119005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220119005.